Daily Digest: Cannabis Impact on Adolescent Brain in 2026
2026 cannabis adolescent brain vulnerability is a growing concern among researchers. Studies link teen cannabis use to increased psychiatric risks such as psychosis and depression. Understanding these risks is critical for public health and clinical…
Regulatory Digest: Cannabis Manufacturing Compliance & Rescheduling
Regulatory cannabis manufacturing compliance is evolving with recent rescheduling updates that impact clinical research. These changes aim to standardize pharmaceutical cannabis production. Understanding these regulations is key for advancing cannabis…
Daily Digest: Last 24 Hours: Brain Aging, Driving Safety, and the Global Fight for Patient Access — March 05, 2026
Recent studies on cannabis cognitive aging older adults provide reassuring data about cognitive decline risks. Evidence shows THC blood levels poorly predict driving impairment. Patient access remains a critical issue in the U.S. and U.K. healthcare…
In the Mix: 9 More Cannabis Articles — March 05, 2026
This digest presents cannabis clinical research updates 2026 with 9 articles reviewed and scored below the clinical relevance threshold. Topics include policy, safety, and anxiety research. Each article summary provides insights and source links for…
Oklahoma Seeks to Backtrack on Medical Marijuana as Pitfalls Multiply
Oklahoma medical cannabis regulations face scrutiny as the state considers rolling back its permissive program. Patients relying on medical cannabis should stay informed about potential changes that could disrupt treatment. Regulatory challenges…
The Coming Divide in Cannabis: Why the U.S. Market Remains Out of Reach for Global Operators
Cannabinoid research barriers in the U.S. create challenges for developing evidence-based cannabis medicines. Federal scheduling under the Controlled Substances Act fragments the regulatory environment. This limits patient access to clinically validated…
Cannabinoids in Pediatric Care: Evidence-Based Clinical Review
Cannabinoid use in children is an evolving area with limited rigorous evidence. Most data comes from observational studies rather than controlled trials. This review highlights the current clinical evidence and safety considerations for cannabinoids in…
Use of Medical Marijuana or Hemp Doesn’t Excuse Drug Testing Violations
2026 cannabis federal workplace regulations clarify that medical marijuana or hemp use does not exempt employees from drug testing violations. Patients using medical cannabis may still face employment consequences despite state legalization. Clinicians…
Congressional Debate on Hemp THC Regulation and Farm Bill
The recent farm bill highlights hemp THC regulation challenges amid ongoing federal uncertainty. Hemp-derived THC products remain in a complex legal gray area. Clinicians face difficulties counseling patients due to shifting hemp THC policies.
CED Cannabis Research Digest — February 27, 2026
The cannabis medicine research digest for February 27, 2026, highlights key peer-reviewed studies scored for clinical relevance. This weekly digest provides a curated summary of cannabis research to inform patient care. Stay updated with the latest…
